Related Experiment Video

Updated: Aug 19, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

U0126 prevents ERK pathway phosphorylation and interleukin-1beta mRNA production after cerebral ischemia

Zhi-qiu Wang1, Xian-cheng Chen, Guo-yuan Yang

  • 1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040. zhiqiuwang@yahoo.com

Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih
|January 27, 2005
PubMed
Abstract

Insights

The MEK inhibitor U0126 reduces key signaling molecules and IL-1beta mRNA in ischemic brain injury. This suggests U0126 offers neuroprotection by inhibiting the ERK pathway in cerebral ischemia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Cerebral ischemia triggers complex signaling pathways, including the extracellular signal-regulated kinase (ERK) pathway.
  • Understanding the role of ERK in ischemic brain injury is crucial for developing neuroprotective strategies.

Purpose of the Study:

  • To investigate the role of the ERK pathway in cerebral ischemia.
  • To elucidate the mechanism by which U0126, a MEK inhibitor, exerts protective effects against ischemic brain injury.

Main Methods:

  • Mice models of cerebral ischemia were established using middle cerebral artery occlusion (MCAO).
  • U0126 was administered intravenously to assess its impact on signaling molecules.
  • Western blot, immunohistochemistry, and ribonuclease protection assay were used to measure protein and mRNA levels.

Main Results:

  • U0126 administration dose-dependently and time-dependently reduced phosphorylated ERK1/2 (pERK1/2), phosphorylated MEK (pMEK), and phosphorylated Elk-1 (pElk-1) in ischemic brain tissue.
  • Interleukin-1beta (IL-1beta) mRNA levels, which increased after MCAO, were downregulated by U0126 treatment.
  • These molecular changes correlated with potential neuroprotective outcomes.

Conclusions:

  • Intravenous U0126 effectively inhibits the upregulation of pMEK, pERK1/2, and pElk-1 induced by cerebral ischemia.
  • The neuroprotective effects of U0126 are likely mediated by the inhibition of the ERK pathway, leading to reduced IL-1beta mRNA expression.
  • This study highlights the therapeutic potential of targeting the ERK pathway in managing ischemic brain injury.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...